Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CL.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CL.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FK.1.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FK.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FK.1.2.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FK.1.2.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FK.1.2.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FK.1.2.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FK.1.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FK.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XBC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
XBC.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBC.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBC.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBC.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.26.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.26.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.26.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.26.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.26.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.26.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.26.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.26.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DS.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
DS.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DS.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
DS.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
DS.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
DS.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DS.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DS.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.11EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.11ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.1.11ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.1.11EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.1.11EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.1.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.11.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.11.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.11.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.11.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.11.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.11.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.11.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.11.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used